Everything you need to know before becoming a member.
Independent research reports on biotechnology, AI, and undervalued growth companies, scored using the Exactis 100™ methodology by three independent analysts before publication.
No. Exactis Alpha is a publisher of financial research for informational and educational purposes. See our Terms of Use and Disclaimer for full details.
$39/month or $399/year, with a discounted $299/year rate for the first 100 Founding Members.
Bio is built for biotechnology and life sciences companies, weighted toward clinical catalysts and scientific data. Growth is built for AI, technology, and defense & security companies, weighted toward market potential and valuation.
Yes. Monthly and annual memberships can be cancelled at any time from your account settings.
We publish only when a company clears our Exactis 100™ threshold — we prioritize quality and consensus over a fixed publishing schedule.